These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 31040621)
21. How do we manage vaccinations in patients with inflammatory bowel disease? Esteve Comas M; Loras Alastruey C; Fernandez-Bañares F Dig Dis; 2009; 27(3):370-4. PubMed ID: 19786767 [TBL] [Abstract][Full Text] [Related]
23. The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease. Seo YB; Moon SJ; Jeon CH; Song JY; Sung YK; Jeong SJ; Kwon KT; Kim ES; Kim JH; Kim HA; Park DJ; Park SH; Park JK; Ahn JK; Oh JS; Yun JW; Lee JH; Lee HY; Choi MJ; Choi WS; Choi YH; Choi JH; Heo JY; Cheong HJ; Lee SS Infect Chemother; 2020 Jun; 52(2):252-280. PubMed ID: 32618150 [TBL] [Abstract][Full Text] [Related]
25. IMMUNIZATION STATUS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Strasse KLA; Jamur CM; Marques J; Kim MSM; Petterle RR; Amarante HMBDS Arq Gastroenterol; 2019 Aug; 56(2):124-130. PubMed ID: 31460574 [TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related]
27. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines. Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412 [TBL] [Abstract][Full Text] [Related]
29. Immunizations for HIV-infected adults: indications, timing, and response. Spach DH Top HIV Med; 2006 Dec-2007 Jan; 14(5):154-8. PubMed ID: 17237556 [TBL] [Abstract][Full Text] [Related]
30. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000. Halsey NA; Hyman SL; Pediatrics; 2001 May; 107(5):E84. PubMed ID: 11331734 [TBL] [Abstract][Full Text] [Related]
31. Vaccine-Preventable Diseases in Hospitalized Patients With Inflammatory Bowel Disease: A Nationwide Cohort Analysis. Vinsard DG; Wakefield D; Vaziri H; Karagozian R Inflamm Bowel Dis; 2019 Nov; 25(12):1966-1973. PubMed ID: 31067308 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines. Rothstein EP; Bernstein HH; Glode MP; Laussucq S; Nonenmacher J; Long SS; Hackell JG Am J Dis Child; 1993 Aug; 147(8):854-7. PubMed ID: 8394646 [TBL] [Abstract][Full Text] [Related]
33. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA; Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433 [TBL] [Abstract][Full Text] [Related]
34. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia. Ercan TE; Soycan LY; Apak H; Celkan T; Ozkan A; Akdenizli E; Kasapçopur O; Yildiz I J Pediatr Hematol Oncol; 2005 May; 27(5):273-7. PubMed ID: 15891564 [TBL] [Abstract][Full Text] [Related]
35. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK. Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304 [TBL] [Abstract][Full Text] [Related]
36. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Davis RL; Kramarz P; Bohlke K; Benson P; Thompson RS; Mullooly J; Black S; Shinefield H; Lewis E; Ward J; Marcy SM; Eriksen E; Destefano F; Chen R; Arch Pediatr Adolesc Med; 2001 Mar; 155(3):354-9. PubMed ID: 11231801 [TBL] [Abstract][Full Text] [Related]
37. Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease. Nguyen HT; Minar P; Jackson K; Fulkerson PC World J Gastroenterol; 2017 Nov; 23(42):7644-7652. PubMed ID: 29204064 [TBL] [Abstract][Full Text] [Related]
38. The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants. Zimmermann P; Donath S; Perrett KP; Messina NL; Ritz N; Netea MG; Flanagan KL; van der Klis FRM; Curtis N; Vaccine; 2019 Jun; 37(28):3735-3744. PubMed ID: 31153688 [TBL] [Abstract][Full Text] [Related]
39. Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. Taddei C; Ceccherini V; Niccolai G; Porchia BR; Boccalini S; Levi M; Tiscione E; Santini MG; Baretti S; Bonanni P; Bechini A Hum Vaccin Immunother; 2014; 10(9):2612-22. PubMed ID: 25483489 [TBL] [Abstract][Full Text] [Related]
40. Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis. Desalermos A; Pimienta M; Kalligeros M; Shehadeh F; Diamantopoulos L; Karamanolis G; Caldera F; Farraye FA Inflamm Bowel Dis; 2022 Sep; 28(9):1430-1442. PubMed ID: 34849941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]